CBD: full UK 2026 guide

What CBD is and how it works

CBD (cannabidiol) is a naturally occurring compound found in hemp varieties of cannabis. Non-psychoactive: does not produce intoxication. Mechanism: interacts with the human endocannabinoid system (ECS). The ECS regulates mood, sleep, pain, appetite, immune function via two main receptor types (CB1 and CB2) plus serotonin (5-HT1A) and other receptors. CBD does not bind directly to CB1 like THC does; instead it modulates ECS activity indirectly. Source: hemp varieties of cannabis sativa with less than 0.2% THC content; grown under Home Office licence in UK. Extraction: CO2 extraction (most common, cleanest), ethanol extraction, oil extraction. UK production: limited UK growing licences; most UK CBD imports from EU, US, Canada.

UK legal status 2026

Legal for adults aged 18+ but with significant compliance requirements. CBD itself is not a controlled substance under UK law. Legal requirements for UK CBD products. THC content: maximum 1mg per container (Misuse of Drugs Act 1971). Hemp source: must be grown under Home Office licence; THC content less than 0.2% in plant. Novel Food authorisation: required for ingestible CBD products from FSA. As of April 2026 FSA has not yet granted any final authorisation but many products on Public List remain on sale. CBD daily intake guidance: 10mg per day for healthy adults (advisory). 18+ age verification: most UK retailers operate Challenge 25. UK regulatory grey areas. CBD flower (smokable hemp): NOT clearly legal; June 2023 Court of Appeal ruling reduced prosecution risk but did not legalise. CBD products without Novel Food applications: technically non-compliant. Medicinal claims: prohibited without MHRA licence (only Epidyolex has UK medicinal licence).

Claimed benefits and research

CBD is studied for various health benefits but UK regulators do not permit medicinal claims without licence. Areas of research. Anxiety: studies suggest CBD may help; mechanism via serotonin (5-HT1A) receptors. Sleep: indirect benefit through anxiety reduction. Pain and inflammation: research into chronic pain, arthritis, post-exercise recovery. Epilepsy: only confirmed UK medicinal use is Epidyolex (CBD prescription drug for severe epilepsy syndromes Lennox-Gastaut and Dravet). Stress: claimed reduction in cortisol levels. PTSD: ongoing research. Skin conditions: topical CBD studied for acne, eczema, psoriasis. UK regulatory position: MHRA has only licensed Epidyolex as UK CBD medicine. Other CBD products cannot legally claim to treat, cure or prevent specific conditions. UK consumers using CBD for wellness should consult GP, particularly if taking medications (CBD interacts with many drugs).

CBD vs THC vs other cannabinoids

Two of the most studied cannabinoids but with different effects and legal status. CBD (cannabidiol): non-psychoactive; does not produce high; UK legal under 1mg THC per container; common in oils, capsules, gummies, vape liquids. THC (tetrahydrocannabinol): psychoactive; produces high; UK Class B controlled substance under Misuse of Drugs Act 1971; legal exceptions: Epidyolex, medical cannabis prescriptions. Other cannabinoids. CBN (cannabinol): mild psychoactive; controlled. CBG (cannabigerol): non-psychoactive; legal status similar to CBD. CBDA (cannabidiolic acid): non-psychoactive precursor; legal. UK practical guide: reputable UK CBD products less than 0.2% THC in source hemp; finished product less than 1mg THC per container. Drug testing: CBD does not show on standard tests; trace THC in full-spectrum CBD theoretically could trigger positive (rare). UK consumers concerned about THC choose CBD isolate or broad-spectrum.

UK CBD product types

Six main categories. CBD oils and tinctures: sublingual drops; fastest absorption among ingestible; UK strengths 250-2000mg per 10ml; £15-60. CBD capsules and tablets: pre-measured doses; slower onset due to digestion. CBD gummies and edibles: chewable sweets; longest onset (1-2 hours). CBD drinks and beverages: ready-to-drink; brand examples Goodrays, TRIP. CBD vape liquids and CBD vapes: inhaled CBD aerosol; faster absorption; not classified as Novel Food but vape regulations still apply. CBD topical creams and balms: applied to skin; localised effect. Three CBD spectrum types. CBD isolate: pure CBD, no other cannabinoids, no THC. Broad-spectrum: multiple cannabinoids, no THC. Full-spectrum: all cannabinoids including trace THC (under 1mg per container). UK retailer brands: Goodrays, Mission C, Bud and Tender, Cannaray, Pureis. UK Vape Tax from 1 October 2026 will apply to CBD vape liquids at £2.20 per 10ml.

Dosing and safety

UK FSA recommends maximum 10mg CBD per day for healthy adults. Practical UK dosing guide. Beginner: 5-10mg/day; assess over 1-2 weeks. Moderate: 10-20mg/day; many UK products designed at this level. Higher doses (above 25mg): not recommended without medical supervision. Factors affecting individual response. Body weight; metabolism; method of consumption; tolerance over time; other medications (CBD interacts with blood thinners, antiepileptics, antidepressants). UK groups who should NOT take CBD: under-18s; pregnant or breastfeeding; trying to conceive; immunosuppressed; on prescription medications (consult GP first). Side effects: drowsiness, dry mouth, reduced appetite, diarrhoea (less common); usually mild. Drug interactions: significant with blood thinners (warfarin), antiepileptics, antidepressants, immunosuppressants. UK practical advice: start low, go slow; consult GP; choose products with third-party lab certificates of analysis (COA) showing exact CBD content and THC level.

For CBD edibles see our CBD edibles collection. For CBD vape legality see are CBD vapes legal in the UK.

For more on UK CBD options head over to our full vaping guides hub.